Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

The Effect of Aging on Tissues

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Aging

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Artificial Intelligence-Based CTA Software for Real-World Detection of Large Vessel Occlusion in Acute Ischemic Stroke.

European neurology·2026

Same author

Dynamic Contrast-Enhanced Ultrasound for Carotid Plaque Characterization: An Algorithm-Aware Technical Review.

Diagnostics (Basel, Switzerland)·2026

Same author

Understanding CT Perfusion in Acute Ischemic Stroke: How Algorithms Shape Perfusion Maps.

Diagnostics (Basel, Switzerland)·2026

Same author

Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuum.

Brain : a journal of neurology·2026

Same author

Tenecteplase for Acute Non-Large Vessel Occlusion After Ischemic Stroke.

JAMA·2026

Same author

Sleep breathing disorders and cardioneurological complications: from pathophysiology to endotype-driven precision management.

Heart (British Cardiac Society)·2026

Search research articles

Related Experiment Video

Updated: May 23, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Sleep-related migraine occurrence increases with aging.

Sara Gori¹, Cinzia Lucchesi, Nicola Morelli

¹Department of Neurosciences, Institute of Neurology, University of Pisa, Via Roma, 67, 56126 Pisa, Italy. s.gori@med.unipi.it

Acta Neurologica Belgica

|March 28, 2012

Summary

Migraine attacks occurring during sleep or upon waking increase with age, particularly in older adults. This suggests aging impacts circadian rhythms and sleep regulation in migraine without aura.

Related Experiment Videos

Last Updated: May 23, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster

Published on: October 20, 2023

Area of Science:

Neurology
Chronobiology
Sleep Medicine

Background:

Migraine without aura often occurs at night or in the early morning, indicating a link between migraine, sleep, and circadian rhythm disruption.
Previous research suggests a connection between sleep patterns and migraine frequency, but the influence of aging requires further investigation.

Purpose of the Study:

To investigate the prevalence of sleep-related migraine in a large cohort of migraineurs across different age groups.
To assess the impact of aging, gender, and comorbidities like psychiatric diseases on the occurrence of sleep-related migraine.

Main Methods:

734 patients diagnosed with migraine without aura (International Headache Society criteria, 2004) were enrolled.
Participants were categorized into five age groups (21-70 years).
Sleep-related migraine was defined as at least 75% of attacks occurring during sleep or upon awakening. Data were collected using headache diaries, the Pittsburgh Sleep Quality Index, and the Beck Depression Inventory.

Main Results:

The occurrence of sleep-related migraine significantly increased with age, rising from 16% in the 20-30 age group to 58% in the 61-70 age group.
This age-related increase was observed irrespective of gender.
Poor sleep quality and depression did not correlate with the timing of migraine attacks (night-time or awakening).

Conclusions:

Aging plays a primary role in the increased incidence of nocturnal and early morning migraine attacks in patients with migraine without aura.
These findings support the hypothesis that impaired chronobiological mechanisms and sleep regulation contribute to sleep-related migraine.
Further research into age-related changes in circadian rhythms and sleep is warranted for understanding and managing migraine.